Differential roles of Kras and Pten in murine leukemogenesis
2 Erickson-Miller CL, Delorme E, Tian SS, Hopson CB, Landis AJ, Valoret EI et al. Preclinical
activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Stem Cells 2009; 27: 424–430. 3 Takeshita A, Shinjo K, Izumi M, Ling P, Nakamura S, Naito
K et al. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients
with acute myeloid leukaemia and acute lymphoblastic leukaemia. Br J Haematol 1998; 100:
283–290. 4 Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoit Y et al …
activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Stem Cells 2009; 27: 424–430. 3 Takeshita A, Shinjo K, Izumi M, Ling P, Nakamura S, Naito
K et al. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients
with acute myeloid leukaemia and acute lymphoblastic leukaemia. Br J Haematol 1998; 100:
283–290. 4 Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoit Y et al …
2 Erickson-Miller CL, Delorme E, Tian SS, Hopson CB, Landis AJ, Valoret EI et al. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells 2009; 27: 424–430. 3 Takeshita A, Shinjo K, Izumi M, Ling P, Nakamura S, Naito K et al. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. Br J Haematol 1998; 100: 283–290. 4 Corazza F, Hermans C, D’Hondt S, Ferster A, Kentos A, Benoit Y et al. Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia. Blood 2006; 107: 2525–2530. 5 Gurney AL, Wong SC, Henzel WJ, de Sauvage FJ. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and
nature.com